Logo image of BAYA

BAYVIEW ACQUISITION CORP-A (BAYA) Stock Fundamental Analysis

NASDAQ:BAYA - Nasdaq - KY07323B1007 - Common Stock - Currency: USD

10.82  +0.01 (+0.09%)

Fundamental Rating

1

BAYA gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. BAYA may be in some trouble as it scores bad on both profitability and health. BAYA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BAYA had positive earnings in the past year.
BAYA had a negative operating cash flow in the past year.
BAYA Yearly Net Income VS EBIT VS OCF VS FCFBAYA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 0 20K -20K 40K 60K 80K

1.2 Ratios

Industry RankSector Rank
ROA 4.77%
ROE 5.13%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BAYA Yearly ROA, ROE, ROICBAYA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 0 0.05 0.1

1.3 Margins

BAYA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BAYA Yearly Profit, Operating, Gross MarginsBAYA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023

More info and screens

2

2. Health

2.1 Basic Checks

BAYA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BAYA Yearly Shares OutstandingBAYA Yearly Shares OutstandingYearly Shares Outstanding 2023 2M 4M 6M
BAYA Yearly Total Debt VS Total AssetsBAYA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 20M 40M 60M

2.2 Solvency

BAYA has an Altman-Z score of 12.93. This indicates that BAYA is financially healthy and has little risk of bankruptcy at the moment.
BAYA has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 12.93
ROIC/WACCN/A
WACCN/A
BAYA Yearly LT Debt VS Equity VS FCFBAYA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 0 10M 20M 30M 40M 50M

2.3 Liquidity

BAYA has a Current Ratio of 0.49. This is a bad value and indicates that BAYA is not financially healthy enough and could expect problems in meeting its short term obligations.
BAYA has a Quick Ratio of 0.49. This is a bad value and indicates that BAYA is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.49
Quick Ratio 0.49
BAYA Yearly Current Assets VS Current LiabilitesBAYA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 20M 40M 60M

More info and screens

0

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8512.22%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BAYA Yearly Revenue VS EstimatesBAYA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023
BAYA Yearly EPS VS EstimatesBAYA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BAYA is valuated quite expensively with a Price/Earnings ratio of 45.08.
BAYA is valuated expensively when we compare the Price/Earnings ratio to 29.63, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 45.08
Fwd PE N/A
BAYA Price Earnings VS Forward Price EarningsBAYA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BAYA Per share dataBAYA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BAYA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BAYVIEW ACQUISITION CORP-A

NASDAQ:BAYA (2/20/2025, 8:00:24 PM)

10.82

+0.01 (+0.09%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners70.87%
Inst Owner Change-77.45%
Ins Owners7.25%
Ins Owner Change0%
Market Cap58.86M
AnalystsN/A
Price TargetN/A
Short Float %0.03%
Short Ratio0.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 45.08
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.62
P/tB 1.62
EV/EBITDA N/A
EPS(TTM)0.24
EY2.22%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0
BVpS6.68
TBVpS6.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.77%
ROE 5.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.49
Quick Ratio 0.49
Altman-Z 12.93
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8512.22%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A